Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04432454
Title Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (ELAINEII)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Sermonix Pharmaceuticals Inc.

Her2-receptor negative breast cancer


Abemaciclib + Lasofoxifene

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) - Comprehensive Cancer Center Birmingham Alabama 35294-3300 United States Details
Yuma Regional Medical Center Yuma Arizona 85364 United States Details
Compassionate Cancer Care Med Group - Clinic Aid USA - Fountain Valley Fountain Valley California 92708 United States Details
St. Joseph Health Santa Rosa California 95403 United States Details
Mayo Jacksonville Jacksonville Florida 32224 United States Details
Illinois Cancer Care Peoria Illinois 61704 United States Details
Beacon Health System Memorial Regional Cancer Center South Bend Indiana 46601 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
New Jersey Cancer Care, PA Belleville New Jersey 07109 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Oncology Consultants, P.A. Houston Texas 77030 United States Details
Hematology Oncology Associates of Fredericksburg Fredericksburg Virginia 22408 United States Details
Northwest Medical Specialists, PLLC (NWMS) Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from for the field